Nicole Erin Kinsey White

Array ( [id] => 6958382 [patent_doc_number] => 20050214752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Compositions and methods for determining epistatic relationships between HIV mutations that affect replication capacity' [patent_app_type] => utility [patent_app_number] => 11/092204 [patent_app_country] => US [patent_app_date] => 2005-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18912 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214752.pdf [firstpage_image] =>[orig_patent_app_number] => 11092204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12408543 [patent_doc_number] => 09969780 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-05-15 [patent_title] => Tat complexes, and vaccines comprising them [patent_app_type] => utility [patent_app_number] => 10/597926 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9016 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10597926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 300000 [patent_doc_number] => 07538201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Recombinant herpesvirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/594449 [patent_app_country] => US [patent_app_date] => 2005-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7104 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538201.pdf [firstpage_image] =>[orig_patent_app_number] => 10594449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250153 [patent_doc_number] => 20050142134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'LFA-1 alpha subunit antibodies and methods of use' [patent_app_type] => utility [patent_app_number] => 11/062290 [patent_app_country] => US [patent_app_date] => 2005-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14594 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142134.pdf [firstpage_image] =>[orig_patent_app_number] => 11062290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040243 [patent_doc_number] => 20070092525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual' [patent_app_type] => utility [patent_app_number] => 10/588633 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15856 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092525.pdf [firstpage_image] =>[orig_patent_app_number] => 10588633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766887 [patent_doc_number] => 20060018930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Compositions comprising viruses and methods for concentrating virus preparations' [patent_app_type] => utility [patent_app_number] => 11/053181 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7819 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018930.pdf [firstpage_image] =>[orig_patent_app_number] => 11053181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6930809 [patent_doc_number] => 20050281844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Immunization for Ebola virus infection' [patent_app_type] => utility [patent_app_number] => 11/038933 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7463 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20050281844.pdf [firstpage_image] =>[orig_patent_app_number] => 11038933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 579391 [patent_doc_number] => 07449190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Assays for assembly of Ebola virus nucleocapsids' [patent_app_type] => utility [patent_app_number] => 11/031921 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 60 [patent_no_of_words] => 15142 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449190.pdf [firstpage_image] =>[orig_patent_app_number] => 11031921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428521 [patent_doc_number] => 20090087831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'METHODS FOR EVALUATING A BACTERIOPHAGE PREPARATION' [patent_app_type] => utility [patent_app_number] => 11/721422 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7420 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087831.pdf [firstpage_image] =>[orig_patent_app_number] => 11721422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648405 [patent_doc_number] => 20060134137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Transduction vector based on modified HIV-2' [patent_app_type] => utility [patent_app_number] => 11/015131 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7903 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134137.pdf [firstpage_image] =>[orig_patent_app_number] => 11015131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843434 [patent_doc_number] => 20060121579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Regulated nucleic acid expression system' [patent_app_type] => utility [patent_app_number] => 11/011264 [patent_app_country] => US [patent_app_date] => 2004-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10197 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121579.pdf [firstpage_image] =>[orig_patent_app_number] => 11011264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5034201 [patent_doc_number] => 20070098740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Stabilisation of viral microparticles' [patent_app_type] => utility [patent_app_number] => 10/580769 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4361 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098740.pdf [firstpage_image] =>[orig_patent_app_number] => 10580769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040657 [patent_doc_number] => 20070092939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'HUMAN IMMUNODEFICIENCY VIRUS ENTRY INHIBITOR ASSAY' [patent_app_type] => utility [patent_app_number] => 10/580703 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5529 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092939.pdf [firstpage_image] =>[orig_patent_app_number] => 10580703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 344974 [patent_doc_number] => 07498161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-03 [patent_title] => 'Mutant herpes simplex viruses comprising nucleic acid encoding a nitroreductase' [patent_app_type] => utility [patent_app_number] => 10/579606 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 34 [patent_no_of_words] => 20133 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/498/07498161.pdf [firstpage_image] =>[orig_patent_app_number] => 10579606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876767 [patent_doc_number] => 07358334 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-04-15 [patent_title] => 'B cell-targeted toxins for humoral immune response reduction and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/985487 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 11095 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358334.pdf [firstpage_image] =>[orig_patent_app_number] => 10985487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6951795 [patent_doc_number] => 20050226889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Inhibition of viral infection and spread with viral and RhoA-derived peptides' [patent_app_type] => utility [patent_app_number] => 10/984377 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14962 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226889.pdf [firstpage_image] =>[orig_patent_app_number] => 10984377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085020 [patent_doc_number] => 20070275071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Use of Microparticles for Antigen Delivery' [patent_app_type] => utility [patent_app_number] => 10/577974 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23296 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275071.pdf [firstpage_image] =>[orig_patent_app_number] => 10577974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5642299 [patent_doc_number] => 20060280754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins' [patent_app_type] => utility [patent_app_number] => 10/578013 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12883 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20060280754.pdf [firstpage_image] =>[orig_patent_app_number] => 10578013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688632 [patent_doc_number] => 20070106066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Cherkasky fusion proteins containing antibody-, antigen- and microtubule-binding regions and immune response-triggering regions' [patent_app_type] => utility [patent_app_number] => 10/577613 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 3589 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20070106066.pdf [firstpage_image] =>[orig_patent_app_number] => 10577613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7987581 [patent_doc_number] => 08076085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Methods and means relating to hepatitis B infection' [patent_app_type] => utility [patent_app_number] => 10/578848 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 8377 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/076/08076085.pdf [firstpage_image] =>[orig_patent_app_number] => 10578848 [rel_patent_id] =>[rel_patent_doc_number] =>)